From: Biomarkers for screening of lung cancer and pre-neoplastic lesions in a high risk Chilean population
A | HA % (N) | ||||||
---|---|---|---|---|---|---|---|
Variable % (N) | WLB % (N) | Normal | Inflammation | Hyperplasia | Metaplasia | Dysplasia | LC |
Normal | 23.47 (23) | 17.39 (4) | 4.35 (1) | 56.52 (13) | 21.74 (5) | 0 | 0 |
Inflammation (a) | 61.22 (60) | 11.67 (7) | 28.33 (17) | 48.33 (29) | 6.67 (4) | 5.0 (3) | 0 |
Suspicious (b) | 3.06 (3) | 0 | 100 (3) | 0 | 0 | 0 | |
LC | 12.25 (12) | 0 | 0 | 0 | 0 | 25.0 (3) | 75.0 (9) |
TOTAL | (98) | (11) | (21) | (42) | (9) | (6) | (9) |
B | HA% (N) | ||||||
Variable % (N) | AFB % (N) | Normal | Inflammation | Hyperplasia | Metaplasia | Dysplasia | LC |
Normal | 18.36 (18) | 22.22 (4) | 5.56 (1) | 61.11 (11) | 11.11 (2) | 0 | 0 |
Inflammation (a) | 57.14 (56) | 12.5 (7) | 30.35 (17) | 50.0 (28) | 5.36 (3) | 1.79 (1) | 0 |
Suspicious (b) | 12.25 (12) | 0 | 25.0 (3) | 25.0 (3) | 33.33 (4) | 16.67 (2) | 0 |
LC | 12.25 (12) | 0 | 0 | 0 | 0 | 25.0 (3) | 75.0 (9) |
TOTAL | 98 | 11 | 21 | 42 | 9 | 6 | 9 |